Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP228965.RAVMTQgUj0CshxORLksioW5XWIuFApGdqmDi46gFZEGZE130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP228965.RAVMTQgUj0CshxORLksioW5XWIuFApGdqmDi46gFZEGZE130_assertion type Assertion NP228965.RAVMTQgUj0CshxORLksioW5XWIuFApGdqmDi46gFZEGZE130_head.
- NP228965.RAVMTQgUj0CshxORLksioW5XWIuFApGdqmDi46gFZEGZE130_assertion description "[ACE (angiotensin-converting enzyme) inhibitors and ARBs (angiotensin II receptor blockers) are already widely used for the treatment and prevention of cardiovascular disease and their potential role in other disease states has become increasingly recognized.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP228965.RAVMTQgUj0CshxORLksioW5XWIuFApGdqmDi46gFZEGZE130_provenance.
- NP228965.RAVMTQgUj0CshxORLksioW5XWIuFApGdqmDi46gFZEGZE130_assertion evidence source_evidence_literature NP228965.RAVMTQgUj0CshxORLksioW5XWIuFApGdqmDi46gFZEGZE130_provenance.
- NP228965.RAVMTQgUj0CshxORLksioW5XWIuFApGdqmDi46gFZEGZE130_assertion SIO_000772 22757959 NP228965.RAVMTQgUj0CshxORLksioW5XWIuFApGdqmDi46gFZEGZE130_provenance.
- NP228965.RAVMTQgUj0CshxORLksioW5XWIuFApGdqmDi46gFZEGZE130_assertion wasDerivedFrom befree-20150227 NP228965.RAVMTQgUj0CshxORLksioW5XWIuFApGdqmDi46gFZEGZE130_provenance.
- NP228965.RAVMTQgUj0CshxORLksioW5XWIuFApGdqmDi46gFZEGZE130_assertion wasGeneratedBy ECO_0000203 NP228965.RAVMTQgUj0CshxORLksioW5XWIuFApGdqmDi46gFZEGZE130_provenance.